Related Experiment Video

Updated: Aug 21, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

[Soft tissue sarcoma in children and adolescents: experiences of the cooperative Soft Tissue Sarcoma Group Studies

I B Brecht1, J Treuner

  • 1Abteilung für Pädiatrische Onkologie und Hämatologie, Olgahospital Stuttgart.

Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V
|October 27, 2004
PubMed

Insights

Paediatric soft tissue sarcomas, including rhabdomyosarcomas, are rare childhood cancers with variable outcomes. Multimodal treatment and risk stratification improve survival rates for affected children and adolescents.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Sarcoma Research

Context:

  • Paediatric soft tissue sarcomas represent approximately 7% of childhood malignancies.
  • Rhabdomyosarcomas constitute over half of these cases, with numerous rare subtypes.
  • Prognosis is highly dependent on histological subtype, patient age, tumor characteristics, and disease extent.

Purpose:

  • To analyze treatment outcomes and prognostic factors in a large cohort of pediatric soft tissue sarcoma patients.
  • To refine risk stratification strategies for improved therapeutic planning.
  • To evaluate the effectiveness of multimodal treatment approaches.

Summary:

  • A cohort of 2918 children and adolescents with soft tissue sarcomas were treated prospectively from 1981-1996 under Cooperative Soft Tissue Sarcoma Study Group (CWS) protocols.
  • Risk stratification was refined based on established prognostic factors.
  • Multimodal therapy involving surgery, chemotherapy, and radiotherapy, guided by multidisciplinary teams, was employed.

Impact:

  • The study achieved an overall survival rate of nearly 70% across all risk groups.
  • Highlights the importance of tailored, multidisciplinary treatment strategies for pediatric soft tissue sarcomas.
  • Provides valuable data for future research and clinical management of these rare cancers.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...